메뉴 건너뛰기




Volumn 35, Issue 4, 2015, Pages 981-989

Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: Results from the confirm (coronary CT angiography evaluation for clinical outcomes: An international multicenter registry) registry

(31)  Chow, Benjamin J W a   Small, Gary a   Yam, Yeung a   Chen, Li a   McPherson, Ruth a   Achenbach, Stephan b   Al Mallah, Mouaz c   Berman, Daniel S x   Budoff, Matthew J e   Cademartiri, Filippo f,g   Callister, Tracy Q h   Chang, Hyuk Jae i   Cheng, Victor Y d   Chinnaiyan, Kavitha j   Cury, Ricardo k   Delago, Augustin l,m   Dunning, Allison a   Feuchtner, Gundrun p   Hadamitzky, Martin q   Hausleiter, Jörg q   more..


Author keywords

aspirin; coronary angiography; coronary atherosclerosis; mortality; prognosis; statin

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT;

EID: 84931262246     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304351     Document Type: Article
Times cited : (158)

References (33)
  • 2
    • 77349086611 scopus 로고    scopus 로고
    • Prognostic value of 64-slice cardiac computed tomography severity of coronary artery disease, coronary atherosclerosis, and left ventricular ejection fraction
    • Chow BJ, Wells GA, Chen L, Yam Y, Galiwango P, Abraham A, Sheth T, Dennie C, Beanlands RS, Ruddy TD. Prognostic value of 64-slice cardiac computed tomography severity of coronary artery disease, coronary atherosclerosis, and left ventricular ejection fraction. J Am Coll Cardiol. 2010;55:1017-1028. doi: 10.1016/j.jacc.2009.10.039.
    • (2010) J Am Coll Cardiol. , vol.55 , pp. 1017-1028
    • Chow, B.J.1    Wells, G.A.2    Chen, L.3    Yam, Y.4    Galiwango, P.5    Abraham, A.6    Sheth, T.7    Dennie, C.8    Beanlands, R.S.9    Ruddy, T.D.10
  • 3
    • 79959302822 scopus 로고    scopus 로고
    • Ontario multidetector computed tomographic coronary angiography study: Field evaluation of diagnostic accuracy
    • Chow BJ, Freeman MR, Bowen JM, et al. Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy. Arch Intern Med. 2011;171:1021-1029. doi: 10.1001/ archinternmed.2011.74.
    • (2011) Arch Intern Med. , vol.171 , pp. 1021-1029
    • Chow, B.J.1    Freeman, M.R.2    Bowen, J.M.3
  • 4
    • 21344460533 scopus 로고    scopus 로고
    • Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: A comparative study with quantitative coronary angiography and intravascular ultrasound
    • Leber AW, Knez A, von Ziegler F, Becker A, Nikolaou K, Paul S, Wintersperger B, Reiser M, Becker CR, Steinbeck G, Boekstegers P. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: A comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol. 2005;46:147-154. doi: 10.1016/j.jacc.2005.03.071.
    • (2005) J Am Coll Cardiol. , vol.46 , pp. 147-154
    • Leber, A.W.1    Knez, A.2    Von Ziegler, F.3    Becker, A.4    Nikolaou, K.5    Paul, S.6    Wintersperger, B.7    Reiser, M.8    Becker, C.R.9    Steinbeck, G.10    Boekstegers, P.11
  • 5
    • 77957049654 scopus 로고    scopus 로고
    • Lesion characteristics and coronary stent selection with computed tomographic coronary angiography: A pilot investigation comparing CTA, QCA and IVUS
    • Kass M, Glover CA, Labinaz M, So DY, Chen L, Yam Y, Chow BJ. Lesion characteristics and coronary stent selection with computed tomographic coronary angiography: A pilot investigation comparing CTA, QCA and IVUS. J Invasive Cardiol. 2010;22:328-334.
    • (2010) J Invasive Cardiol. , vol.22 , pp. 328-334
    • Kass, M.1    Glover, C.A.2    Labinaz, M.3    So, D.Y.4    Chen, L.5    Yam, Y.6    Chow, B.J.7
  • 9
    • 70350360003 scopus 로고    scopus 로고
    • 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations
    • Genest J, McPherson R, Frohlich J, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Can J Cardiol. 2009;25:567-579.
    • (2009) Can J Cardiol. , vol.25 , pp. 567-579
    • Genest, J.1    McPherson, R.2    Frohlich, J.3
  • 11
    • 77954179995 scopus 로고    scopus 로고
    • Statins and all-cause mortality in high-risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65,229 participants
    • Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, Sattar N. Statins and all-cause mortality in high-risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med. 2010;170:1024-1031. doi: 10.1001/archinternmed.2010.182.
    • (2010) Arch Intern Med. , vol.170 , pp. 1024-1031
    • Ray, K.K.1    Seshasai, S.R.2    Erqou, S.3    Sever, P.4    Jukema, J.W.5    Ford, I.6    Sattar, N.7
  • 14
  • 15
    • 0015966216 scopus 로고
    • Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve
    • Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974;33:87-94.
    • (1974) Am J Cardiol. , vol.33 , pp. 87-94
    • Gould, K.L.1    Lipscomb, K.2    Hamilton, G.W.3
  • 16
    • 0027987849 scopus 로고
    • Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-1389.
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 17
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
    • Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-1622.
    • (1998) JAMA. , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3    Whitney, E.4    Shapiro, D.R.5    Beere, P.A.6    Langendorfer, A.7    Stein, E.A.8    Kruyer, W.9    Gotto, A.M.10
  • 18
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
    • Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-1307. doi: 10.1056/NEJM199511163332001.
    • (1995) N Engl J Med. , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3    Isles, C.G.4    Lorimer, A.R.5    Macfarlane, P.W.6    McKillop, J.H.7    Packard, C.J.8
  • 19
    • 0037164314 scopus 로고    scopus 로고
    • PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial
    • Shepherd J, Blauw GJ, Murphy MB, et al.; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet. 2002;360:1623-1630.
    • (2002) Lancet. , vol.360 , pp. 1623-1630
    • PROSPER study group1    Shepherd, J.2    Blauw, G.J.3    Murphy, M.B.4
  • 20
    • 33746431474 scopus 로고    scopus 로고
    • Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)
    • Knopp RH, d'Emden M, Smilde JG, Pocock SJ. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care. 2006;29:1478-1485. doi: 10.2337/dc05-2415.
    • (2006) Diabetes Care. , vol.29 , pp. 1478-1485
    • Knopp, R.H.1    D'emden, M.2    Smilde, J.G.3    Pocock, S.J.4
  • 22
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360:7-22.
    • (2002) Lancet , vol.360 , pp. 7-22
  • 23
    • 84859480711 scopus 로고    scopus 로고
    • Evidence-based use of statins for primary prevention of cardiovascular disease
    • Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS. Evidence-based use of statins for primary prevention of cardiovascular disease. Am J Med. 2012;125:440-446. doi: 10.1016/j.amjmed.2011.11.013.
    • (2012) Am J Med. , vol.125 , pp. 440-446
    • Minder, C.M.1    Blaha, M.J.2    Horne, A.3    Michos, E.D.4    Kaul, S.5    Blumenthal, R.S.6
  • 25
    • 79958001356 scopus 로고    scopus 로고
    • The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary
    • Bell AD, Roussin A, Cartier R, et al. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary. Can J Cardiol. 2011;27:208-221. doi: 10.1016/j. cjca.2010.12.033.
    • (2011) Can J Cardiol. , vol.27 , pp. 208-221
    • Bell, A.D.1    Roussin, A.2    Cartier, R.3
  • 26
    • 33644556119 scopus 로고    scopus 로고
    • Visualizing coronary calcium is associated with improvements in adherence to statin therapy
    • Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006;185:394-399. doi: 10.1016/j. atherosclerosis.2005.06.018.
    • (2006) Atherosclerosis. , vol.185 , pp. 394-399
    • Kalia, N.K.1    Miller, L.G.2    Nasir, K.3    Blumenthal, R.S.4    Agrawal, N.5    Budoff, M.J.6
  • 27
    • 41049105993 scopus 로고    scopus 로고
    • Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors
    • Orakzai RH, Nasir K, Orakzai SH, Kalia N, Gopal A, Musunuru K, Blumenthal RS, Budoff MJ. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol. 2008;101:999-1002. doi: 10.1016/j. amjcard.2007.11.059.
    • (2008) Am J Cardiol. , vol.101 , pp. 999-1002
    • Orakzai, R.H.1    Nasir, K.2    Orakzai, S.H.3    Kalia, N.4    Gopal, A.5    Musunuru, K.6    Blumenthal, R.S.7    Budoff, M.J.8
  • 29
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. N Engl J Med 1998; 339:1349-1357.
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 31
    • 0001667150 scopus 로고    scopus 로고
    • The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 2002;288:2998-3007.
    • (2002) JAMA , vol.288 , pp. 2998-3007
    • ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group1
  • 32
    • 0037420492 scopus 로고    scopus 로고
    • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
    • Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet. 2003;361:1149-1158. doi: 10.1016/ S0140-6736(03)12948-0.
    • (2003) Lancet. , vol.361 , pp. 1149-1158
    • ASCOT investigators1    Sever, P.S.2    Dahlöf, B.3    Poulter, N.R.4    Wedel, H.5    Beevers, G.6    Caulfield, M.7    Collins, R.8    Kjeldsen, S.E.9    Kristinsson, A.10    McInnes, G.T.11    Mehlsen, J.12    Nieminen, M.13    O'brien, E.14    Ostergren, J.15


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.